Increased dabigatran plasma concentration during Ibrutinib treatment: a case of cerebral hemorrhage and successful dabigatran reversal by idarucizumab-Reference-Cited by-同舟云学术

Increased dabigatran plasma concentration during Ibrutinib treatment: a case of cerebral hemorrhage and successful dabigatran reversal by idarucizumab

Published:2017-04-26 Issue:1 Volume:30 Page:93-95
ISSN:1720-8319
Container-title:Aging Clinical and Experimental Research
language:en
Short-container-title:Aging Clin Exp Res

Author:

Quintavalla R.,Lombardi M.,Prandoni P.,Manotti C.,Tadonio I.,Re F.,Ferrini P. M.,Tassoni M. I.,Rossetti P.,Quaini F.

Publisher

Springer Science and Business Media LLC

Subject

Geriatrics and Gerontology,Aging

Link

http://link.springer.com/article/10.1007/s40520-017-0752-5/fulltext.html

Reference5 articles.

1. Byrd JC, Furman RR, Coutre SE et al (2015) Three-year follow-up of treatment-naive and previously treated patients with CLL and SLL receiving single-agent ibrutinib. Blood 125:2915

2. Lipsky AH, Farooqui MZH, Tian X et al (2015) Incidence and risk factors of bleeding-related adverse in patients with chronic lymphocytic leukemia treated with ibrutinib. Haematologica 100:1571–1578

3. Berglof A, Hamasy A, Meinke S et al (2015) Targets for Ibrutinib beyond B cell malignancies. Scand J Immunol 82:208–217

4. McMullen JR, Boey EJH, Ooi JYY et al (2014) Ibrutinib increases the risk of atrial fibrillation, potentially through inhibition of cardiac PI3K-Akt signaling. Blood 124:3829–3830

5. Ruff CT, Giugliano RP, Braunwald E et al (2014) Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 383:955–962

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bleeding risk with concurrent use of anticoagulants and ibrutinib: A population‐based nested case‐control study;British Journal of Haematology;2023-07-24

2. Standard operating procedure for idarucizumab reversal of dabigatran anticoagulation in ischemic and hemorrhagic stroke;Journal of Thrombosis and Thrombolysis;2023-02-04

3. Ibrutinib-associated symptomatic intracerebral haemorrhage following IV thrombolysis for acute ischaemic stroke;Acta Neurologica Belgica;2022-03-28

4. Dabigatran Reversal With Idarucizumab and In-Hospital Mortality in Intracranial Hemorrhage: A Systematic Review of Real-Life Data From Case Reports and Case Series;Frontiers in Neurology;2021-11-24

5. Dabigatran in ibrutinib-treated patients with atrial fibrillation and chronic lymphocytic leukemia: experience of three cases;Blood Coagulation & Fibrinolysis;2020-12-02